Recent findings, reported on November 15, 2025, have cast a shadow over one of the most anticipated breakthroughs in ...

In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

Nearly 7 million Americans currently live with Alzheimer’s and by 2060, experts say that number could be as high as 14 ...

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars annually. If someone you know has Alzheimer’s, you’ve likely experienced ...

Scientists tested the substance on rats with positive results and are now seeking partnerships with pharmaceutical companies to conduct clinical trials. A research team at the Federal University of AB ...

Kinney Drugs is partnering with the Alzheimer's Association to present a free webinar. Attendees will learn the ten early ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking ...

New research has found that the loss of social memory – recognizing friends and family – in Alzheimer's disease (AD) could ...